Tens of Thousands of Commercial Truckers Leaving the Workforce Over Marijuana Testing Requirements Washington, DC - January 27, 2023 (Investorideas.com Newswire) Over 40,000 commercially licensed truck drivers failed federally mandated drug screens for marijuana in 2022, and many did not reapply to return to work |
National Cannabis Industry Association Responds to FDA Statement on Cannabidiol (CBD) Regulation Washington, DC - January 26, 2023 (Investorideas.com Newswire) Today the Food and Drug Administration announced that it has concluded that regulations governing food and supplements would not be appropriate for Cannabidiol (CBD) products and that the agency will work with Congress to develop a new way forward. |
Study: Marijuana Legalization Not Associated with Elevated Rates of Psychosis-Related Health Outcomes Washington, DC - January 26, 2023 (Investorideas.com Newswire) State-level marijuana legalization laws are not associated with a statistically significant increase in rates of psychosis-related health outcomes |
Presidential Marijuana Pardon Applications Still Unavailable Months After White House Announcement Washington, DC - January 25, 2023 (Investorideas.com Newswire) The National Organization for the Reform of Marijuana Laws (NORML) is urging the Biden Administration to expeditiously move forward on its promise to provide pardons for low-level federal marijuana convictions. |
Hemp Stock News: Global Hemp Group (CSE: GHG) Announces Execution of Exclusive Licensing Agreement for the Intellectual Property of Apollon Formularies PLC Covering the United States, Canada, and Mexico Vancouver, British Columbia - January 23, 2023 (Newsfile Corp.) (Investorideas.com Newswire) GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) is pleased to announce that further to the Company's announcement of January 11, 2023 regarding the execution of the binding LOI with Apollon Formularies Plc - (AQSE: APOL), the Parties have now executed an exclusive licensing agreement dated January 19, 2023 covering the licensing of the right to Apollon's Patent Applications and the Technology for the United States, Canada, and Mexico. |
Investor Ideas Cannabis Potcasts #643: Interview with CEO of Tilt Holdings Inc. (OTC: TLLTF) (NEO: TILT) Vancouver, Delta, Kelowna, BC - January 17, 2023 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts. |
Smoakland Adds Extra Delivery Vans Around Stadium for 49ers Playoff Game Santa Clara, CA - January 12, 2023 (Investorideas.com Newswire) Smoakland cannabis delivery service is adding extra delivery vans around Levi's Stadium this Sunday following a meteoric 530% increase in sales during last week's playoff game against the Cardinals. |
Viridian's Thursday Valuation Tracker January 12, 2023 (Investorideas.com Newswire) This week's Viridian Value Tracker focuses on the valuation statistics of the 15 U.S Cultivation & Retail companies with over $100M market cap. |
Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis, CBD and Psychedelics Industry January 2nd, 2022 - January 6th, 2022 January 11, 2023 (Investorideas.com Newswire) Two capital raise transactions totaling $2.7M closed this week. One more transaction closed than last week, and the volume was up by $1.7M. |
Hemp Stock News - Global Hemp Group (CSE: GHG) Announces Execution of Binding LOI with Apollon Formularies PLC Vancouver, British Columbia - January 11, 2023 (Newsfile Corp.) (Investorideas.com Newswire) GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) is pleased to announce that it has executed a binding Letter of Intent with Apollon Formularies Plc - (AQSE: APOL), a UK-based international pharmaceutical company developing cancer treatments from natural biologics |